Showing results (421-430 of 445) with videos related to
Sort By:
Pageof 45
Neuro-Oncology|September 4, 2023
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect groupPhilipp Karschnia, Jorg Dietrich, Francesco Bruno, et al.Neuro-Oncology|September 27, 2023
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomasAtsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, et al.The Journal of Clinical Investigation|December 9, 2021
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomasHirokazu Ogino, Jennie W Taylor, Takahide Nejo, et al.Proceedings of the National Academy of Sciences of the United States of America|September 17, 2017
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1Tali Mazor, Charles Chesnelong, Aleksandr Pankov, et al.Neuro-Oncology|June 5, 2013
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesisKyle M Walsh, Terri Rice, Paul A Decker, et al.Neuro-Oncology|August 12, 2022
Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Antonio Dono, et al.Nature|May 3, 2023
Glioblastoma remodelling of human neural circuits decreases survivalSaritha Krishna, Abrar Choudhury, Michael B Keough, et al.Science Advances|June 4, 2025
Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learningMulki Mehari, Gayathri Warrier, Abraham Dada, et al.Cell Transplantation|October 5, 2007
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patientsY Torrente, M Belicchi, C Marchesi, et al.Neuro-Oncology|April 8, 2022
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomesYalan Zhang, Calixto-Hope G Lucas, Jacob S Young, et al.Pageof 45